← Back to Search

Behavioural Intervention

Vibro-Acoustic Therapy for Parkinson's Disease

N/A
Recruiting
Led By Prabesh Kanel, PhD
Research Sponsored by University of Michigan
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up after 90-120 days of intervention
Awards & highlights

Study Summary

This trial tested a device to treat Parkinson's; results showed it had positive effects.

Who is the study for?
This trial is for people with Parkinson's Disease at stage 2 or higher, who may or may not be on dopaminergic therapy. Participants should be able to use smart devices and have a fear of falling or anxiety disorders. It excludes those with certain skin conditions, on specific medications like beta-blockers, pregnant women, individuals with brain surgery history or pacemakers, and those diagnosed with dementia.Check my eligibility
What is being tested?
The study tests a vibro-acoustic therapy device called Apollo Neuro on individuals with Parkinson's Disease to see if it can improve their condition. This small pilot study will explore the potential benefits of this non-invasive treatment option.See study design
What are the potential side effects?
Since this is an exploratory study using a non-invasive device, side effects are expected to be minimal but could include discomfort where the device touches the skin or possible interference with sleep patterns.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~after 90-120 days of intervention
This trial's timeline: 3 weeks for screening, Varies for treatment, and after 90-120 days of intervention for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Average Nighttime Heart Rate Variability
Beck Anxiety Inventory score
Beck Depression Inventory score
+15 more

Trial Design

1Treatment groups
Experimental Treatment
Group I: Parkinson's DiseaseExperimental Treatment1 Intervention
Participants will use the vibro-acoustic device 90-120 days for 6 hours at night on the Apollo Neuro setting "Sleep and Renew".

Find a Location

Who is running the clinical trial?

University of MichiganLead Sponsor
1,798 Previous Clinical Trials
6,378,128 Total Patients Enrolled
Prabesh Kanel, PhDPrincipal InvestigatorUniversity of Michigan

Media Library

Transcutaneous Vibro-Acoustic Therapy (Behavioural Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT05962476 — N/A
Parkinson's Disease Research Study Groups: Parkinson's Disease
Parkinson's Disease Clinical Trial 2023: Transcutaneous Vibro-Acoustic Therapy Highlights & Side Effects. Trial Name: NCT05962476 — N/A
Transcutaneous Vibro-Acoustic Therapy (Behavioural Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05962476 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there still opportunities to partake in this clinical experiment?

"Indeed, the clinicaltrials.gov website attests to this medical trial's ongoing recruitment efforts which began on August 9th 2023 and were last updated a day later. At present, 10 participants from 1 facility are required for the study."

Answered by AI

How many individuals have signed up to participate in this research investigation?

"Yes, the information available on clinicaltrials.gov verifies that this research project is still open for participant recruitment. It was first published on August 9th 2023 and has been updated as recently as August 10th 2023. The investigators are hoping to find 10 volunteers from a single site."

Answered by AI
~6 spots leftby Jul 2025